MedRx Co., Ltd (TYO: 4586)
Japan
· Delayed Price · Currency is JPY 82.00
+2.00 (2.50%)
Dec 30, 2024, 3:45 PM JST
MedRx Balance Sheet
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 2,332 | 1,720 | 994 | 1,703 | 1,812 | 1,410 | Upgrade
|
| Cash & Short-Term Investments | 2,332 | 1,720 | 994 | 1,703 | 1,812 | 1,410 | Upgrade
|
| Cash Growth | 24.97% | 73.04% | -41.63% | -6.02% | 28.51% | -21.49% | Upgrade
|
| Accounts Receivable | 23 | - | - | - | - | - | Upgrade
|
| Other Receivables | 17 | 33 | 15 | 23 | 37 | 35 | Upgrade
|
| Receivables | 40 | 33 | 15 | 23 | 37 | 35 | Upgrade
|
| Inventory | 13 | 10 | 8 | 11 | 19 | 18 | Upgrade
|
| Other Current Assets | 33 | 22 | 70 | 17 | 18 | 38 | Upgrade
|
| Total Current Assets | 2,418 | 1,785 | 1,087 | 1,754 | 1,886 | 1,501 | Upgrade
|
| Property, Plant & Equipment | 132 | 181 | 226 | 270 | 328 | 471 | Upgrade
|
| Long-Term Investments | 161 | 85 | 84 | 83 | 82 | 75 | Upgrade
|
| Other Long-Term Assets | 1 | 1 | 1 | 1 | 1 | - | Upgrade
|
| Total Assets | 2,712 | 2,052 | 1,398 | 2,108 | 2,297 | 2,047 | Upgrade
|
| Short-Term Debt | - | - | - | - | 50 | - | Upgrade
|
| Current Income Taxes Payable | 84 | 98 | 156 | 124 | 71 | 112 | Upgrade
|
| Other Current Liabilities | 2 | 1 | 2 | 1 | 1 | 4 | Upgrade
|
| Total Current Liabilities | 86 | 99 | 158 | 125 | 122 | 116 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | 4 | 5 | 5 | 5 | 1 | Upgrade
|
| Other Long-Term Liabilities | 4 | 26 | 24 | 23 | 23 | 10 | Upgrade
|
| Total Liabilities | 90 | 129 | 187 | 153 | 150 | 127 | Upgrade
|
| Common Stock | 573 | 847 | 227 | 7,803 | 7,376 | 6,704 | Upgrade
|
| Additional Paid-In Capital | 2,307 | 1,916 | 3,063 | 7,372 | 6,945 | 6,273 | Upgrade
|
| Retained Earnings | -300 | -915 | -2,150 | -13,279 | -12,219 | -11,105 | Upgrade
|
| Comprehensive Income & Other | 42 | 75 | 71 | 59 | 45 | 48 | Upgrade
|
| Shareholders' Equity | 2,622 | 1,923 | 1,211 | 1,955 | 2,147 | 1,920 | Upgrade
|
| Total Liabilities & Equity | 2,712 | 2,052 | 1,398 | 2,108 | 2,297 | 2,047 | Upgrade
|
| Total Debt | - | - | - | - | 50 | - | Upgrade
|
| Net Cash (Debt) | 2,332 | 1,720 | 994 | 1,703 | 1,762 | 1,410 | Upgrade
|
| Net Cash Growth | 24.97% | 73.04% | -41.63% | -3.35% | 24.96% | -21.49% | Upgrade
|
| Net Cash Per Share | 56.58 | 49.46 | 39.19 | 79.74 | 108.46 | 117.18 | Upgrade
|
| Filing Date Shares Outstanding | 45.91 | 38.48 | 30.7 | 24.6 | 19.7 | 13.71 | Upgrade
|
| Total Common Shares Outstanding | 45.91 | 38.37 | 28.22 | 24.6 | 19.44 | 13.71 | Upgrade
|
| Working Capital | 2,332 | 1,686 | 929 | 1,629 | 1,764 | 1,385 | Upgrade
|
| Book Value Per Share | 57.11 | 50.12 | 42.91 | 79.49 | 110.47 | 140.00 | Upgrade
|
| Tangible Book Value | 2,622 | 1,923 | 1,211 | 1,955 | 2,147 | 1,920 | Upgrade
|
| Tangible Book Value Per Share | 57.11 | 50.12 | 42.91 | 79.49 | 110.47 | 140.00 | Upgrade
|
| Order Backlog | - | - | 2 | - | 7.49 | 16.46 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.